Fox Chase Researchers Study ‘Liquid Biopsies’ as Possible Method for Improved Cancer Detection and Monitoring Progression
PHILADELPHIA (March 13, 2020)—Fox Chase Cancer Center researchers have published a study suggesting that genomic profiles measured through circulating free DNA (cfDNA) in the blood of breast cancer patients may provide a more effective way to treat cancer and track its progression.